tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Peter Welford, 19 are a HOLD (27.54%), 40 are a BUY (57.97%), 10 are a SELL (14.49%).
Analyst Peter Welford, carries an average stock price target met ratio of 62.36% that have a potential upside of 24.35% achieved within 545 days. Previously, Peter Welford worked at JEFFERIES.
Peter Welford’s has documented 120 price targets and ratings displayed on 14 stocks. The coverage was on Healthcare, Consumer Cyclical, Basic Materials sectors.
Most recent stock forecast was given on GSK, GlaxoSmithKline PLC ADR at 14-Apr-2026.
Analyst best performing recommendations are on PLX (PROTALIX BIOTHERAPEUTICS).
The best stock recommendation documented was for PLX (PROTALIX BIOTHERAPEUTICS) at 11/9/2012. The price target of $55 was fulfilled within 14 days with a profit of $6 (12.24%) receiving and performance score of 8.75.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 02-Dec-2019
$240
$80.8 (50.75%)
$105
6 months 11 days ago
(30-Mar-2026)
12/15 (80%)
$47.4 (24.61%)
572
Buy Since 27-Jan-2020
$220
$60.8 (38.19%)
$174
6 months 14 days ago
(27-Mar-2026)
5/16 (31.25%)
$32.82 (17.53%)
570
Buy Since 11-Apr-2023
$109
$-50.2 (-31.53%)
$168
7 months 9 days ago
(02-Mar-2026)
1/3 (33.33%)
$-93.39 (-46.14%)
128
Buy Since 05-Sep-2023
$108.5
$-79.91 (-42.41%)
$91.7
10 months 16 days ago
(25-Nov-2025)
1/6 (16.67%)
$-76.04 (-41.21%)
483
Hold Since 27-Oct-2025
11 months 14 days ago
(27-Oct-2025)
2/3 (66.67%)
$-6.12 (-4.81%)
958
